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Deoxyribonuclease (DNase) II in macrophages cleaves the DNA of engulfed apoptotic cells 
and of nuclei expelled from erythroid precursor cells. 
 
DNase II
 
–deficient mouse embryos 
accumulate undigested DNA in macrophages, and die in feto because of the activation of 
the 
 
interferon 
 
 
 
 (
 
IFN
 
 
 
) gene. Here, we found that the F4/80-positive macrophages in 
 
DNase II
 
   
 
 fetal liver specifically produce a set of cytokines such as IFN
 
 
 
, TNF
 
 
 
, and CXCL10. 
Whereas, IFN-inducible genes (2
 
 
 
5
 
 
 
-oligo(A) synthetase, IRF7, and ISG15) were expressed 
not only in macrophages but also in other F4/80-negative cells. When 
 
DNase II
 
   
 
 macrophages 
or embryonal fibroblasts engulfed apoptotic cells, they expressed the 
 
IFN
 
 
 
 and 
 
CXCL10
 
 
genes. The ablation of Toll-like receptor (TLR) 3 and 9, or their adaptor molecules (MyD88 
and TRIF), had no effect on the lethality of the 
 
DNase II
 
   
 
 mice. These results indicate that 
there is a TLR-independent sensing mechanism to activate the innate immunity for the 
endogenous DNA escaping lysosomal degradation.
 
DNA is actively degraded in various mammalian
developmental processes (1). It is degraded in the
programmed cell death that occurs during
embryogenesis; in definitive erythropoiesis in
the fetal liver, spleen, and bone marrow; and in
lens cell differentiation in the eye. DNase II, a
lysosomal enzyme, is expressed in various types
of cells, with prominent expression in macro-
phages  (2). Macrophages engulf the apoptotic
dying cells that are generated during pro-
grammed cell death and digest DNA by DNase
II. Macrophages also engulf and digest the nuclei
expelled from erythroid precursor cells during
erythropoiesis (3).
 
DNase II
 
 
 
/
 
 
 
 mouse embryos accumulate
undigested DNA in macrophages, which are
present in various tissues, such as the thymus,
kidney, interdigit, spleen, and liver (4–6). The
development of lymphocytes and erythrocytes
is severely impaired in 
 
DNase II
 
 
 
/
 
 
 
 embryos
that die in feto (4, 5). We recently found that
the 
 
IFN
 
 
 
 gene is strongly activated in the
 
DNase II
 
 
 
/
 
 
 
 fetal liver and thymus (5). When
 
DNase II
 
 
 
/
 
 
 
 mice were crossed to mice deficient
in the IFN type I receptor (
 
IFN-IR
 
) gene, the
 
DNase II
 
 
 
/
 
 
 
IFN-IR
 
 
 
/
 
 
 
 embryos developed nor-
mally to birth, indicating that IFN
 
 
 
, which is
produced by the macrophages carrying undi-
gested DNA, has a lethal effect on the develop-
ment of mouse embryos (7).
Type I IFNs, to which IFN
 
 
 
 belongs, play a
central role in antiviral innate immunity, and are
used to treat human patients with C-type hep-
atitis and leukemia (8). The effects of IFNs are
the result of their direct inhibitory action against
viral replication in the infected cells, and to their
pleiotropic immunomodulating activity on NK
cells, macrophages, and T lymphocytes (9). Most
cells produce IFN
 
 
 
 when they are infected with
a DNA or RNA virus. Expression of the 
 
IFN
 
 
 
gene is also induced in macrophages and den-
dritic cells by bacterial components such as LPS
and nonmethylated CpG DNA (10, 11). The
signal transduction leading to the 
 
IFN
 
 
 
 gene ex-
pression by viral and bacterial components has
been extensively studied (12–14). According to
these studies, viral and bacterial components bind
to Toll-like receptors (TLRs) expressed on mac-
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rophages and dendritic cells, which leads to the recruitment of
specific adaptor molecules to the receptors. Specifically, TLR3,
TLR4, TLR7, and TLR9 function as signaling receptors for
double-stranded RNA, LPS, viral single-stranded RNA, and
CpG DNA, respectively. An adaptor called MyD88 (myeloid
differentiation primary response gene 88) transduces the signal
from TLR7 or TLR9 to activate the 
 
IFN
 
 
 
 gene. TRIF (Toll/
IL-1 receptor domain-containing adaptor inducing IFN-
 
 
 
), an-
other adaptor, is recruited to TLR3 and TLR4, which leads to
 
IFN
 
 
 
 gene expression through the activation of a transcription
factor called IFN regulatory factor 3 (IRF3).
In this report, we show that macrophages can produce IFN
 
 
 
and CXCL10 (chemokine, CXC motif, ligand) when they can-
not degrade DNA of the engulfed apoptotic cells. We crossed
the lethal 
 
DNase II
 
 
 
/
 
 
 
 embryos to mouse strains deficient in
genes for TLRs or their adaptors, and found that the TLR sys-
tem has little role in the induction of the 
 
IFN
 
 
 
, 
 
CXCL10,
 
 and
 
TNF
 
 
 
 genes by mammalian DNA accumulated in the lyso-
somes of macrophages. These results imply that there is a novel
TLR-independent mechanism that recognizes the undigested
endogenous DNA to activate the innate immune system.
 
RESULTS
Constitutive expression of a set of genes in the macrophages 
of 
 
DNase II
 
 
 
/
 
 
 
 fetal liver
 
The fetal livers of 
 
DNase II
 
 
 
/
 
 
 
 embryos contain many F4/80-
positive macrophages that carry undigested DNA, and consti-
tutively express IFN
 
 
 
 and 
 
 
 
, and IFN-inducible genes. To
examine which genes were primarily activated in these macro-
phages, macrophages of the fetal liver were isolated by mag-
netic-activated cell sorting (MACS) using an antibody against
the macrophage-specific, F4/80 antigen. The F4/80-positive
cells accounted for 
 
 
 
1% (0.3%) of the fetal liver cells from both
wild-type and 
 
DNase II
 
 
 
/
 
 
 
 embryos (Fig. 1 A and not de-
picted). This proportion increased to 6–10% after sorting by
the MACS procedure, whereas almost no F4/80-positive cells
(
 
 
 
0.03%) were found in the F4/80-negative fraction. The en-
richment of F4/80-positive macrophages by the MACS proce-
dure was confirmed by quantifying the F4/80 mRNA level by
real-time PCR. That is, the F4/80 mRNA level in the sorted
fraction was about sixfold that in the same amount of RNA
from unsorted fetal liver cells. In contrast, its level was negligi-
ble in the cells of the F4/80-negative fraction (Fig. 1 B).
The mRNA level of IFN
 
 
 
, IFN
 
 
 
, TNF
 
 
 
, and IFN-
inducible genes (Fig., 1 B, 
 
CXCL10
 
, 
 
2
 
 
 
5
 
 
 
 
 
oligo(A) synthetase
 
[
 
OAS
 
], 
 
IRF7
 
, and 
 
IFN-stimulated gene
 
 
 
15
 
 [
 
ISG15]
 
) was then
quantified by real-time PCR. As shown in Fig. 1 B, the
mRNA for IFN
 
 
 
, TNF
 
 
 
, and CXCL10 was exclusively
found in the F4/80-positive fraction from the 
 
DNase II
 
 
 
/
 
 
 
 fe-
tal liver, suggesting that these genes could have been directly
activated in macrophages carrying undigested DNA. Among
the genes activated in the macrophages of 
 
DNase II
 
 
 
/
 
 
 
 fetal
liver, the absolute level of CXCL10 mRNA was 
 
 
 
10–100
times that of the IFN
 
 
 
 or TNF
 
 
 
 mRNAs. In contrast to
these genes, the IFN
 
 
 
, OAS, IRF7, and ISG15 mRNAs—
the expression of which was also strongly activated in 
 
DNase
II
 
 
 
/
 
 
 
 fetal liver—were found not only in the F4/80-positive
but also in the F4/80-negative fractions. These results indicate
that these genes could be activated secondarily by cytokines
and chemokines produced by the 
 
DNase II
 
 
 
/
 
 
 
 macrophages.
 
Activation of the 
 
CXCL10
 
 and 
 
IFN
 
 
 
 genes in phagocytes 
engulfing apoptotic cells
 
Macrophages engulf apoptotic cells and the nuclei expelled
from erythroid precursor cells, and degrade their DNA using
DNase II in lysosomes (1). To confirm that the undigested
DNA accumulated in macrophages could activate the genes,
W3/Ildm cells, which do not undergo apoptotic DNA frag-
mentation (15), were induced to undergo apoptosis with Fas
ligand, and then added to fetal liver macrophages. As found
previously (5), the primary macrophages from wild-type or
 
DNase II
 
 
 
/
 
 
 
 embryos efficiently engulfed the apoptotic cells;
however, the DNA of the engulfed apoptotic cells was effi-
ciently degraded in the wild-type, but not the 
 
DNase II
 
 
 
/
 
 
 
,
macrophages. The effect of undigested DNA on the gene
expression in macrophages was then quantified by real-time
PCR for CXCL10 mRNA. As shown in Fig. 2, the
Figure 1. Constitutive expression of IFN  and IFN-inducible genes 
by F4/80-positive cells in the DNase II    fetal liver. (A) The fetal liver 
cells from wild-type E14.5 mouse embryos were sorted by MACS using a 
biotinylated anti-F4/80 mAb. The cells retained on (positive fraction) and 
passing through (negative fraction) the column were collected. Aliquots of 
each fraction, as well as the cells before sorting were stained with PI and 
Alexa 488–conjugated streptavidin, and analyzed by flow cytometry. The 
staining profiles for F4/80 in the PI-negative fraction are shown. (B) RNA 
was prepared from DNase II /  ( / ) or DNase II /  ( / ) fetal liver 
cells before sorting (open bar), the population enriched for F4/80-positive 
cells (closed bar), and the F4/80-negative cells (gray bar). The mRNA level 
for F4/80 antigen (GenBank/EMBL/DDBJ accession no. X93328), IFN  
(NM_010510), IFN  (NM_008337), TNF  (NM_013693), CXCL10 (M33266), 
2 5 -OAS (BC013715), IRF7 (NM_016850), and ISG15 (NM_015783) was 
quantified by real-time PCR, and expressed as copy number per nanogram 
of total RNA. JEM VOL. 202, November 21, 2005 1335
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CXCL10 mRNA level in the DNase II /  macrophages en-
gulfing apoptotic cells was about twice that in the wild-type
macrophages. The increase of CXCL10 mRNA was spe-
cific, because no induction of the  -actin gene was observed
in the DNase II /  macrophages engulfing apoptotic cells.
Mouse embryonal fibroblasts (MEF) transformed with
 v 3 integrin efficiently engulf apoptotic cells in the presence
of milk fat globule EGF factor 8 (MFG-E8) (16). To confirm
that the CXCL10 gene could be activated by mammalian
DNA, wild-type and DNase II /  MEF expressing  v 3 inte-
grin were established. As expected, both the wild-type and
DNase II /  MEF efficiently engulfed apoptotic thymocytes
in the presence of MFG-E8; but, condensed undigested nu-
clear DNA was found only in the DNase II /  MEF (Fig. 3
A). The CXCL10 mRNA level was similar between the
wild-type and DNase II /  MEF when they were incubated
without apoptotic cells (Fig. 3 B). However, its level increased
4.4-fold when the DNase II /  MEF were incubated with ap-
optotic cells. When chloroquine, which inhibits the acidifica-
tion of lysosomes (17), was added to the engulfment assay, the
DNA of the engulfed thymocytes remained undigested even
in the wild-type MEF, and this was accompanied by activa-
tion of the CXCL10 gene. These results confirmed that undi-
gested chromosomal DNA in the lysosomes of phagocytes
could activate the CXCL10 gene. Similarly, the IFN 
mRNA, detected as a 368-bp RT-PCR product, was found
when  DNase II /  but not wild-type MEF was incubated
with apoptotic thymocytes (Fig. 3 C). To further confirm that
the deficiency of the DNase II gene (whereby there is no
DNA degradation in lysosomes), is responsible for the activa-
tion of CXCL10 gene, the DNase II gene was introduced into
DNase II /  MEF. As shown in Fig. 3 D, the stable transfor-
mants reexpressing DNase II did not accumulate undigested
DNA in lysosomes, and the expression level of CXCL10 was
reduced to that observed with the wild-type MEF.
No involvement of a Toll-like receptor system in the IFN  
gene activation in DNase II /  embryos
Bacterial DNA activates the innate immune system via TLR9
in a MyD88-dependent manner (12, 13), whereas double-
stranded RNA such as poly(I)(C), activates the IFN  gene via
the TLR3–TRIF pathway. To examine whether the endoge-
nous DNA that escapes lysosomal degradation uses any of
these TLRs and adaptors to activate the IFN  gene, DNase
II / TLR9 / , DNase II / TLR3 / , DNase II / MyD88 / ,
and DNase II / TRIF /  mice were intercrossed. The ge-
notype analysis of their neonatal offspring did not reveal dou-
ble-deficient mice lacking any of these genes with the DNase
II gene, which is in a sharp contrast to the result with DNase
II / IRF-IR /  embryos (Table I). Embryos that carry the
corresponding genotypes could be found at a normal Mende-
lian ratio at embryonic day (E)12.5, indicating that the dou-
ble-deficient mice died at the late stage of embryogenesis like
DNase II /  embryos. Real-time PCR analysis of RNA from
Figure 2. In vitro activation of the CXCL10 gene in macrophages 
engulfing apoptotic cells. Apoptotic W3/Ildm cells were added to primary 
macrophages from the DNase II /  or DNase II /  fetal liver at a 10:1 ratio, 
incubated at 37 C for 2 h, and stained with Feulgen. (left panel, left micro-
graph) Original magnification, 200; bar, 50  m. A single macrophage carrying 
apoptotic cells is also shown at a higher magnification in the right micro-
graph. Original magnification, 400; bar, 20  m. In the right panels, mac-
rophages from DNase II /  (open bar) or DNase II /  (closed bar) fetal liver 
were cultured with or without apoptotic W3/Ildm cells for 6 h. The  -actin 
and CXCL10 mRNA levels were determined by real-time PCR, and normalized 
to the expression level of F4/80 mRNA. Experiments were performed three 
times, and the mean values are shown with standard deviation (error bars).
Table I. No effect of the null mutation of TLR9, TLR3, MyD88, 
or TRIF on the lethality of DNase II /  embryos
Genotypes DNase II /  DNase II /  DNase II / 
 /  29 50 0
TLR9 /  42 65 0
TLR3 /  14 29 0
MyD88 /  14 37 0
TRIF /  35 73 0
MyD88 /  TRIF /  61 2 0
IFN-IR /  19 36 23
Mouse parents carrying the DNase II / TLR9-/-, DNase II / TLR3 / , DNase II /  
MyD88 / , DNase II / TRIF / , DNase II / MyD88 / TRIF / genotypes were 
intercrossed, and the genotype for the DNase II gene in their offspring was determined 
by PCR. The number of offspring carrying the indicated genotype is shown. Results of 
the intercross between DNase II / IFN-IR /  are from Yoshida et al. (7).TLR-INDEPENDENT GENE INDUCTION BY MAMMALIAN DNA | Okabe et al. 1336
the liver of these double-deficient embryos indicated that the
IFN , CXCL10, and TNF  mRNAs were expressed as
abundantly as in the DNase II /  embryos (Fig. 4). To further
confirm no involvement of TLR in activation of the innate
immune system in the DNase II /  embryos, the DNase II / 
MyD88 / TRIF /  mice were established. As shown in Ta-
ble I, the intercross of these DNase II /  MyD88 / TRIF / 
mice did not produce triple mutant mice that carry the DNase
II /  MyD88 / TRIF /  genotype. These results indicated
that TLR3, TLR9, or other TLRs that use MyD88 or TRIF
adaptor were not involved in activating the IFN  gene by the
endogenous DNA accumulated in lysosomes.
DISCUSSION
Systemic lupus erythematosus is characterized by the pro-
duction of autoantibodies against single-stranded or double-
Figure 3. In vitro activation of the CXCL10 and IFN  genes in 
embryonal fibroblasts engulfing apoptotic cells. (A) Accumulation of 
the undigested DNA in DNase II /  MEF. DNase II /  or DNase II /  MEF 
were transformed to express  v 3-integrin. Apoptotic CAD /  thymocytes 
were added to the MEF at 125:1, incubated at 37 C for 20 h in the presence of 
0.1  g/ml mouse MFG-E8 with or without chloroquine, stained with 
DAPI, and observed by microscopy. (left and right) Original magnification, 
100; bars, 50  m. A single MEF carrying apoptotic cells is shown in the 
middle. Original magnification, 200; bar, 50  m. (B) Activation of the 
CXCL10 gene in DNase II /  MEF. DNase II /  (open bar) or DNase II /  
MEF were allowed to engulf apoptotic CAD /  thymocytes for 20 h in the 
presence of 0.1  g/ml mouse MFG-E8 with or without 10  M chloroquine. 
The expression level for CXCL10 mRNA was determined by real-time PCR and 
was normalized to the expression level of  -actin mRNA. The mean values 
from three independent experiments are plotted with standard deviations 
(error bars). (C) Activation of the IFN  gene in DNase II /  MEF. Immor-
talized MEF from wild-type ( / ) or DNase II /  ( / ) embryos were 
incubated with ( ) or without ( ) apoptotic thymocytes, and the IFN  
mRNA in MEF was analyzed by RT-PCR. RT-PCR for the RNA samples 
from DNase II /  MEF was performed in the presence ( ) or absence ( ) 
of reverse transcriptase (RT). As a control,  -actin mRNA was analyzed by 
RT-PCR. (D) Effect of the reexpression of DNase II in the activation of 
CXCL10 gene in DNase II /  MEF. Integrin   -expressing immortalized 
DNase II /  MEF was transfected with the retrovirus expression vector 
carrying the DNA fragment coding for the Flag-tagged DNase II gene or 
the empty vector. The stable transformants were then incubated with or 
without apoptotic CAD /  thymocytes as described above, and stained 
with DAPI. Original magnification, 100; bar, 50  m. In the right panel, 
the CXCL10 mRNA level was quantified by real-time PCR. The relative 
expression level against  -actin mRNA is shown. The experiments were 
performed three times, and the mean values are shown with standard 
deviations (error bars).JEM VOL. 202, November 21, 2005 1337
ARTICLE
stranded DNA. Patients with systemic lupus erythematosus of-
ten carry circulating DNA in their serum, suggesting that
DNA activates the immune system (18). In fact, bacterial DNA
activates the innate immune system, leading to inflammation
and septic shock, and infection by DNA viruses activates the
IFN  and IFN  genes (10). We previously showed that DNA
derived from apoptotic cells or nuclei expelled from erythroid
precursor cells accumulates in the macrophages of DNase II / 
embryos, activates a group of genes, and kills the embryos by
inducing severe anemia (5, 7). Among the genes activated in
the  DNase II /  fetal liver, several, such as the IFN  and
CXCL10 genes, seem to be directly activated in the macro-
phages by the undigested DNA, whereas others are activated
secondarily through the IFN system (this report and reference 7).
Many groups have studied the signal transduction for ac-
tivation of the innate immune system by DNA using in vitro
and in vivo systems. The exposure of macrophages to naked
bacterial, but not mammalian, DNA activates the innate im-
munity in a TLR9- and MyD88-dependent manner (12, 13,
19). This finding led to the proposal that the unmethylated
CpG motif that is abundant in the bacterial genome is re-
sponsible for the induction of innate immunity by DNA
(10); and, this idea was supported by the observation that
TLR9 recognizes this DNA motif (20). In contrast to this
hypothesis, when a DNA–liposome complex is used to in-
troduce DNA into macrophages, inflammatory responses,
including induction of the IFN  gene, are induced not only
by bacterial DNA but also by mammalian DNA (21). This
response depends on endosomal acidification (21), and partly
requires TLR9 (22). In addition, mammalian DNA–immu-
noglobulin complex activates B cells via TLR9 (23); but, it
activates dendritic cells by both TLR9-dependent and -in-
dependent pathways (24). Apoptotic cells are engulfed by
macrophages, and their DNA is degraded by DNase II in ly-
sosomes (5), implying that the undegraded DNA left in the
DNase II /  macrophages is localized to lysosomes. Thus,
we expected that the IFN  gene induction in DNase II / 
macrophages occurred via TLR9, which can be translocated
to the late endosomes and lysosomes (25). However, a defi-
ciency of TLR9 or its adaptor MyD88 had no effect on the
activation of the IFN  and CXCL10 genes in DNase II / 
embryos. The treatment of DNase II /  phagocytes with
chloroquine, which inhibits the TLR9-mediated signaling
(26), had no effect on the expression of the CXCL10 gene
expression, confirming that TLR9 is not involved in this sys-
tem. In addition, TLR3 deficiency also did not rescue the le-
thality of the DNase II /  embryos, indicating that TLR3,
which is responsible for poly(I)(C)-induced IFN  gene ex-
Figure 4. No involvement of TLR9, TLR3, MyD88, or TRIF in the 
IFN , CXCL10, and TNF  gene activation in DNase II /  embryos. 
RNA was prepared from the liver of wild-type, TLR9 / , TLR3 / , MyD88 / , 
TRIF / , DNase II / , DNase II / TLR9 / , DNase II / TLR3 / , 
DNase II / MyD88 / , and DNase II / TRIF /  embryos at E12.5. The 
mRNA level for IFN , CXCL10, and TNF  was determined by real-time 
PCR, and is plotted as a relative value to  -actin mRNA with standard 
deviations.TLR-INDEPENDENT GENE INDUCTION BY MAMMALIAN DNA | Okabe et al. 1338
pression (27), does not play a role in the IFN  gene activa-
tion in DNase II /  macrophages. Signaling from the other
TLRs (TLR1–2 and TLR5–8) is mediated by MyD88 or
TRIF adaptor (12, 13). Single- and double-null mutations of
the MyD88 or TRIF gene failed to rescue the lethality of
DNase II /  embryos. These results indicate that TLRs, at
least the known TLRs, are not likely to be involved in acti-
vation of the IFN , CXCL10, and TNF  genes by mam-
malian DNA accumulated in macrophages.
The IFN  and CXCL10 genes carry a similar element
called IFN stimulus response element (ISRE) or the IRF el-
ement on their promoter (28, 29). LPS, poly(I)(C), and vi-
ruses activate the IFN  and CXCL10 genes by activating
IRF3 or IRF7, which binds to the ISRE on their promoter
(30, 31). Recently, a TLR-independent pathway that acti-
vates IRF3 via an RNA helicase was established for viral
RNA (32, 33). It will be interesting to examine the possible
involvement of IRF3 and/or IRF7 in the activation of IFN 
and CXCL10 genes by undigested mammalian DNA in ly-
sosomes. The TNF  gene promoter carries NF- B and AP-1
binding sites. LPS, bacterial DNA, and viral RNA activate
the  TNF  gene through a TLR-dependent JNK–NF- B
pathway. Our results indicate that the TNF  gene induction
in DNase II /  macrophages is also TLR independent. How
this gene is activated by the mammalian DNA that escaped
from lysosomal degradation remains to be studied. 
Type I IFN and TNF  have a major effect on various
autoimmune diseases (34, 35). A large amount of chromo-
somal DNA, which is potentially immunogenic, is degraded
in our bodies during erythropoiesis and programmed cell
death. Elucidation of the molecular mechanism by which
undigested mammalian DNA leads to the IFN and TNF 
production will help us identify candidate targets for the
therapeutic intervention of these autoimmune diseases.
MATERIALS AND METHODS
Mice.  The CAD / , DNase II / , MyD88 / , TRIF / , TLR3 / , and
TLR9 /  mice were described previously (4, 5, 20, 36–38). The mice were
housed in a specific pathogen-free facility at Osaka University Medical
School or Oriental Bioservice Inc. All animal experiments were performed
in accordance with protocols approved by the Osaka University Medical
School Animal Care and Use Committee. The genotype of the DNase II,
MyD88, TRIF, TLR3, and TLR9 genes was determined by PCR using
the primers listed in the supplemental materials (available at http://
www.jem.org/cgi/content/full/jem.20051654/DC1). All mice except
TRIF /  mice, that were backcrossed three times, were backcrossed to
C57BL/6 strain at least six generations.
Cells and reagents.  A derivative of mouse T cell lymphoma (WR19L,
ATCC TIB 52) expressing mouse Fas and a caspase-resistant form of
ICAD-L (W3/Ildm) was described previously (15). Fetal liver macrophages
were prepared essentially as described previously (39). In brief, the livers
from E14.5 embryos were dissected and passed through a 22-gauge needle
five times. The cells were washed with PBS, and cultured in a 10-cm sus-
pension culture dish (Corning) with  -MEM containing 10% FBS supple-
mented with mouse macrophage colony-stimulating factor (40). After 2 d,
the cells were vigorously washed, and adherent cells were recovered by in-
cubating at 37 C in PBS containing 0.02% EDTA. The cells were further
cultured for a week and were used as fetal liver macrophages.
MEF were established from E13.5 embryos as described previously
(41). In brief, after removing the head and liver, the torso was minced and
dispersed in PBS containing 0.05% trypsin and 0.5 mM EDTA. After incu-
bating at 37 C for 40 min, DMEM containing 10% FBS was added to the
mixture, and the tissues were dissociated by vigorous pipetting. After allow-
ing the large pieces of tissue debris to settle, the suspended cells were cul-
tured in DMEM containing 10% FBS. In some cases, the cells were cul-
tured for 1 mo by splitting the cultures at 1:4 until they stopped
proliferating. The cells were further maintained by changing the medium
twice a week, and the immortalized cells that started to grow after 1 mo
were expanded. MEF cell lines expressing  v 3-integrin or DNase II were
established by transforming MEF with a retrovirus carrying  v- or  3-inte-
grin or Flag-tagged DNase II as described previously (16). 
Leucine zipper–tagged human Fas ligand (42) and mouse MFG-E8 (16)
were produced in monkey COS7 and human 293T cells, respectively, and
purified to homogeneity as described previously.
Cell sorting and FACS analysis. Cell populations enriched in primary
macrophages from the E14.5 fetal liver were obtained using a MACS column
(MS  Separations; Miltenyi Biotec) according to the instructions provided by
the manufacturer. In brief, the fetal liver cells (2.0   107 cells) were incubated
at 4 C for 20 min with 2.5  g/ml of biotinylated F4/80 antibody (a gift from
Dr. M. Tanaka; clone 6-16A) in 4 ml of MACS buffer (PBS containing 0.5%
BSA and 2 mM EDTA) containing 10  g/ml anti-Fc III/II receptor (BD
Biosciences). The cells were further incubated at 4 C for 20 min with anti-bio-
tin microbeads (80  l, Miltenyi Biotec), and loaded onto a column placed in
a magnetic field. The cells that passed through and were retained on the col-
umn were collected, and used as F4/80-negative and positive cells, respec-
tively. To monitor the sorting procedure, aliquots of the fractionated cells
were stained for 30 min at 4 C with Alexa 488-conjugated streptavidin (Mo-
lecular Probes) and propidium iodide (PI) in staining solution (PBS contain-
ing 2% FBS and 0.05% NaN3), and analyzed by a FACScan flow cytometer
(Becton Dickinson) using Cell Quest software (Quest Software).
Phagocytosis. Phagocytosis was assayed essentially as described previously
(16). In brief, fetal liver macrophages or MEF were cultured in 6-well
plates. Thymocytes from CAD /  mice or W3/Ildm lymphoma cells were
treated for 2 h at 37 C with Fas ligand to induce apoptosis in  50% of the
cells, and then incubated with phagocytes. To stain the DNA of the en-
gulfed apoptotic cells, the phagocytes were washed to remove the surface-
bound cells, fixed with methanol containing 4% formaldehyde and 5% ace-
tic acid, and subjected to Feulgen or DAPI staining.
Real-time PCR. For real-time PCR, total RNA was prepared using the
RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN), and was reverse
transcribed using Superscript III reverse-transcriptase (Invitrogen) with
oligo(dT)12-18 as primer. Aliquots of the reverse transcriptase products were
amplified in a reaction mixture containing LightCycler-FastStart DNA
Master SYBER green I (Roche Molecular Biochemicals) according to the
instructions provided by the manufacturer.
Online supplemental material. Online supplemental material contains
primers that were used to determine the genotype of the DNase II, MyD88,
TRIF, TLR3, and TLR9 genes and primers for real-time PCR. It is avail-
able at http://www.jem.org/cgi/content/full/jem.20051654/DC1.
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